Targeting NF-κB/AP-2β signaling to enhance antitumor activity of cisplatin by melatonin in hepatocellular carcinoma cells

Samankaltaisia teoksia

• Melatonin inhibits AP-2β/hTERT, NF-κB/COX-2 and Akt/ERK and activates caspase/Cyto C signaling to enhance the antitumor activity of berberine in lung cancer cells
  Tekijä: Lu, Jian-Jun, et al.
  Julkaistu: (2015)
• Aspirin enhances the sensitivity of colon cancer cells to cisplatin by abrogating the binding of NF-κB to the COX-2 promoter
  Tekijä: Jiang, Wei, et al.
  Julkaistu: (2020)
• NF-κB and AP-1 Connection: Mechanism of NF-κB-Dependent Regulation of AP-1 Activity
  Tekijä: Fujioka, Shuichi, et al.
  Julkaistu: (2004)
• Melatonin increases the chemosensitivity of diffuse large B-cell lymphoma cells to epirubicin by inhibiting P-glycoprotein expression via the NF-κB pathway
  Tekijä: Liu, Kaili, et al.
  Julkaistu: (2020)
• Melatonin Enhances the Anti-Tumor Effect of Fisetin by Inhibiting COX-2/iNOS and NF-κB/p300 Signaling Pathways
  Tekijä: Yi, Canhui, et al.
  Julkaistu: (2014)